Why the study?
Cellular senescence contributes to aging and cardiovascular pathologies, but knowledge gaps remain regarding its systemic effects and the therapeutic potential of targeting senescence.
Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Senescence-targeted interventions merit exploration in age-related CVD; leaves open clinical translation from current preclinical and observational links.
Kumar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: